A. Epidemiology
- Overall incidence of spontaneous abortion (misscarriage) ~30%
- Occurs in ~15% of known pregnancies
- Up to 1/5 may occur without clinical suspicion
- Actual level of miscarriage may be closer to 50% of conceptions
- Recurrent miscarriage defined as at least 2 or 3 consecutive pregnancy losses
- At least 2 consecutive pregnancy losses in ~5% of couples trying to conceive
- At least 3 consecutive pregnancy losses in ~1% of couples trying to conceive
- Risk of recurrent abortion increases with each spontaneous abortion
- After 2 consecutive losses, risk of 3RD loss is ~20%
- After 3 consecuitve losses, risk of 4TH loss is ~40%
- Spontaneous abortion is a risk factor for major depressive disorder [5]
B. Etiology
- Conception and Development
- Maximum fecundity (probability of conception during one menstrual cycle) ~30%
- Implantation of conceptus >10 days after ovulation associated with pregnancy loss [9]
- 50-60% of all conceptions progress beyond 20 weeks of pregnancy
- Fever in pregnancy is not a risk factor for fetal death [3]
- Genetic Causes of Recurrent Abortion
- Most common cause of 1st trimester spontaneous abortion
- Fetal aneuploidy causes >60% of cases (most are lethal genetic anomalies)
- Autosomal trisomy accounts for >50% of chromosome anomalies
- Other common types include XO (Turner's) and XXY (Klinefelter's)
- Polyploidy accounts for ~22% of genetic anomalies
- Triploidy ~75%, Tetraploidy ~20%
- Parental genetic abnormalities: ~2.5%
- Coagulation protein mutations are clear risk factor (see below) [4]
- Hyperhomocysteinemia - 1.5X increased risk for spontaneous abortion [14]
- Maternal Anatomic Causes
- Cervical incompetence - second trimester losses
- Congenital uterine anomalies - septa, bicornate or unicornate uterus
- Adhesions and Leimyomas most common acquired uterine anomalies
- Maternal Environmental Causes [8]
- Smoking Tobacco - increased risk 1.8X for spontaneous abortion
- Cocaine Abuse - increased risk 1.4X for spontaneous abortion
- Moderate caffeine intake is NOT associated with increase in spontaneous abortion [10]
- Infection
- Infections (Fetal Wastage)
- Toxoplasma gondii - TORCH infection
- Chlamydia
- Ureaplasma and Mycoplasma
- Listeria monocytogenes
- Antiphospholipid Syndrome (APLS)
- Nearly all patients have anti-phospholipid Abs and/or lupus anticoagulant
- Some of these have frank SLE
- Autoreactive type 1 T helper cells may play a role in abortion in some patients
- Likely that the anti-phospholipid Abs induce endothelial damage and/or thrombosis
- Antiphospholipid Abs include anticardiolipin or antiprothrombin Abs
- Prothrombin is cleaved to fragment 1 and prethrombin
- Eleven of 19 women with spontaneous abortion had anti-prothrombin (prethrombin) Abs [13]
- Treatment with prednisone+aspirin does not improve birth rate [6]
- Heparin, with careful monitoring for osteoporosis, may reduce risk of spontaneous abortion
- Endocrine
- Luteal phase defect (<11 days)
- Abnormal Thyroid Function
- Diabetes Mellitus
- ? Abnormal prolactin
- Coagulopathy [4]
- These are generally hereditary disorders
- Antithrombin and Protein C deficiencies have variable influence on fetal loss risk [4]
- Protein S deficiency associated with 7-14 fold increased risk for fetal loss
- Factor V Leiden or Factor II (prothrombin) mutation each increases risk ~2-7 fold [7,11]
- APLS - see above
- Consider screening women for these genetic predispositions
- Anticoagulation should NOT be used in women without evidence of coagulopathy
- However, anticoagulation is effective in antiphospholipid syndrome and should be considered in women with genetic predispositions
- Hyperhomocysteinemia may contribute to coagulopathy [14]
- Caffeine Intake [12]
- Caffeine passes readily through placenta to the fetus
- No association between caffeine intake and first-trimester abortion in smokers
- Caffeine intake associated with slight increase in first-trimester abortion in nonsmokers
- Magnitude of effect in non-smokers 1.3-2.0X for caffeine 100mg to >500mg/day
- This corresponds to 1 to >5 cups of coffee per day
- Some reduction in caffeine intake in first trimester may be beneficial in some women
C. Evaluation
- History
- Family History
- Previous surgeries
- Endometritis, Pelvic Inflammatory Disease
- Autoimmune Disease (including Raynaud's phenomenon, Lupus)
- Idiopathic Deep Vein Thrombosis (DVT)
- Endocrinopathies
- Physical
- Pelvic Exam: Double cervix, midline uterine depression, leiomyomas
- Vaginal Discharge
- Temperature curves (daily for 1-2 months)
- Laboratory Tests
- Thyroid Function Tests, glucose tolerance test
- CBC and Cultures, ? Serology for infectious agents
- Autoimmune screen: APTT, Antiphospholipid Abs, ANA, etc.
- HLA Typing - ? efficacy, role. Both partners.
- Karyotyping of affected partners as indicated - modaics or translocation
- Progesterone levels (if abnormal luteal phase suspected)
- Hysterosaplingogram, hysteroscopy
D. Management Overview
- Progesterone - begin early 1st trimester; modest benefit on reducing miscarriage rate
- Metformin (Glucophage®) - may be beneficial in polycystic ovarian syndrome, diabetes
- Heparin + Aspirin - for use in APLS
- Immunomodulation - no good evidence for benefit (possibly in APLS)
- Embryo aneuploidy screening
- In vitro fertilization
- Depression is very common and should be treated
E. In Vitro Fertilization (IVF)
- Variety of methods for augmenting rates of sperm-egg fertilization
- Overall success rate is about 12% per cycle of IVF
- Factors Associated with Reduced Success Rates
- Age <25 (slight reduction) and >30 years (increasing failure with age)
- Lack of prior pregnancy or live birth
- Increasing number of failed previous cycles
- Male sperm abnormalities
- Increasing duration of infertility
- New methods involving direct sperm injection into egg are being evaluated
- Great concern about bypassing "natural" sperm-egg compatibility processes
- Potential for increased DNA damage on sperm introduction into egg
- This method is called intracytoplasmic sperm injection
References
- Rai R and Regan L. 2006. Lancet. 368(9535):601
- Norwitz ER, Schust DJ, Fisher SJ. 2001. NEJM. 345(19):1400
- Andersen AMN, Vastrup P, Wohlfahrt J, et al. 2002. Lancet. 360(9345):1552
- Rey E, Kahn SR, David M, Shrier I. 2003. Lancet. 361(9360):901
- Neugebauer R, Kline J, Shrout P, et al. 1997. JAMA. 277(5):383
- Laskin CA, Bombardier C, Hannah ME, et al. 1997. NEJM. 337(3):148
- Ridker PM, Miletich JP, Buring JE, et al. 1998. Ann Intern Med. 128(12):1000
- Ness RB, Grisso JA, Hirschinger N, et al. 1999. NEJM. 340(5):333
- Wilcox AJ, Baird DD, Weinberg CR. 1999. NEJM. 340(23):1796
- Klebanoff MA, Levine RJ, DerSimonian R, et al. 1999. NEJM. 342(22):1639
- Martinelli I, Taioli E, Cetin I, et al. 2000. NEJM. 343(14):1015
- Cnattingius S, Signorello LB, Anneren G, et al. 2000. NEJM. 343(25):1839
- Akimoto T, Akama T, Saitoh M, et al. 2001. Am J Med. 110(3):188
- George L, Mills JL, Johansson AL, et al. 2002. JAMA. 288(15):1867